Guardant Health (GH) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US40131M1099
Guardant Health, Inc. is a company dedicated to precision oncology. Based in Palo Alto, California, they operate worldwide, offering innovative blood tests, data solutions, and analytics to aid in cancer detection and treatment.
One of their flagship offerings is Guardant360, a comprehensive test that analyzes genetic markers to guide personalized treatment decisions. They also provide other specialized tests like GuardantOMNI for advanced cancer stages and Shield Test for early-stage treatment selection.
In addition to their testing services, Guardant Health also develops software solutions such as GuardantConnect, which helps connect patients with actionable alterations to relevant clinical studies, enhancing patient care and treatment outcomes.
The company has a strong emphasis on research and collaboration, partnering with prestigious organizations like the Parker Institute for Cancer Immunotherapy to study the impact of molecular cancer biomarkers on patient response to immunotherapy across diverse cancer types.
Guardant Health, Inc. aims to revolutionize cancer care through cutting-edge technologies and collaborative research efforts, making significant strides in advancing precision oncology globally. To learn more about their groundbreaking work, you can visit their website at https://guardanthealth.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
GH Stock Overview
| Market Cap in USD | 1,956m |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| GiC SubIndustry | Health Care Services |
| TER | 0.00% |
| IPO / Inception | 2018-10-04 |
GH Stock Ratings
| Growth 5y | -5.52 |
| Fundamental | -49.9 |
| Dividend | - |
| Rel. Performance vs Sector | -2.94 |
| Analysts | 4.50/5 |
| Fair Price Momentum | 14.06 USD |
| Fair Price DCF | - |
GH Dividends
| Yield 12m | 0.00% |
| Yield on Cost 5y | 0.00% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 0.0% |
GH Growth Ratios
| Growth 12m | -23.09% |
| Growth Correlation 12m | -61% |
| Growth Correlation 3m | -61% |
| CAGR 5y | -23.41% |
| Sharpe Ratio 12m | -0.48 |
| Alpha vs SP500 12m | -53.52 |
| Beta vs SP500 5y weekly | 1.34 |
| ValueRay RSI | 51.77 |
| Volatility GJR Garch 1y | 62.00% |
| Price / SMA 50 | -7.57% |
| Price / SMA 200 | -34.23% |
| Current Volume | 698k |
| Average Volume 20d | 2213.5k |
External Links for GH Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 27, 2024, the stock is trading at USD 17.35 with a total of 697,962 shares traded.
Over the past week, the price has changed by +7.97%, over one month by -1.92%, over three months by -24.89% and over the past year by -17.14%.
According to ValueRays Forecast Model, GH Guardant Health will be worth about 15.4 in April 2025. The stock is currently trading at 17.35. This means that the stock has a potential downside of -11.3%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 39.1 | 125 |
| Analysts Target Price | 53 | 205 |
| ValueRay Target Price | 15.4 | -11.3 |